Ads
related to: 8 week hep c treatment- What Is Hepatitis C
Learn About Hepatitis C & Discover
A Hep C Treatment Option Here.
- FAQs About Hepatitis C
Get The Facts About Hepatitis C &
Read About A Treatment Option Today
- Risks Of Hepatitis C
Read About The Risks Of Hep C And
Explore A Hep C Treatment Here.
- A Hep C Treatment Regimen
Ready To Treat Your Hep C?
Learn About A Treatment Option Here
- Patient Support Program
Looking For Financial Assistance &
Insurance Support? Learn More Here.
- Download A Co-Pay Coupon
Eligible Patients May Pay As Little
As $5 Per Co-Pay For A Treatment
- What Is Hepatitis C
Search results
Results From The WOW.Com Content Network
Ledipasvir is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. [1] After completing Phase III clinical trials, on February 10, 2014, Gilead filed for U.S. approval of a ledipasvir/sofosbuvir fixed-dose combination tablet for genotype 1 hepatitis C. [2] [3] The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication ...
It is a fixed-dose combination of ledipasvir and sofosbuvir. [8] Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. [9] Some evidence also supports use in HCV genotype 3 and 4. [9] It is taken daily by mouth for 8–24 weeks. [8] It is generally well tolerated. [10]
Before 2012, sustained response occurred in about 40–50% of those with HCV genotype 1 who received 48 weeks of treatment. [5] A sustained response was seen in 70–80% of people with HCV genotypes 2 and 3 following 24 weeks of treatment. [5] A sustained response occurs for about 65% of those with genotype 4 after 48 weeks of treatment.
In all cases, after just 12 weeks of treatment, 95 percent of people diagnosed with hepatitis C are cured. How to Prevent Hepatitis C Cured of hepatitis C, however, doesn’t mean immune.
Sofosbuvir is a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus. Skip to main content. Finance. 24/7 Help. For premium support please call: ...
Gilead Sciences' sofosbuvir has gone 4-for-4 in phase 3 trials treating hepatitis C patients. The latest data come from a trial dubbed Fusion, which tested sofosbuvir plus a generic drug called ...
Ad
related to: 8 week hep c treatment